查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1872276

代謝體學試劑－全球市佔率及排名、總收入及需求預測（2025-2031年）

Metabolomics Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 81 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球代謝體學試劑市場在2024年達到 2,940萬美元，預計到2031年將達到 6,980萬美元，在2025年至2031年的預測期內，年複合成長率將達到 13.2%。

代謝體學學試劑是代謝體學研究中用於檢測、定量和分析生物系統中代謝物（小分子化合物）的專用化學物質、化合物或材料。代謝體學是指一套用於全面檢測和分析生物體在生物活動過程中產生的各種代謝物的技術。代謝物的定性和定量變化反映了不斷變化的生物現象，廣泛應用於診斷、生物標記發現和藥物研發。近年來，代謝組學試劑也被應用於食品工業，用於改善食品的口感和品質，開發機能性食品；以及生物技術工業，用於提高發酵和生質燃料的產量。

精準醫療目的是根據個體在基因、環境和生活方式方面的差異，制定個人化的治療方法。代謝物分析在識別疾病特異性生物標記方面發揮關鍵作用，指導個人化治療方案的發展。這一趨勢加速臨床研究和診斷應用中對試劑的需求。

製藥公司正利用代謝體學來更佳了解藥物代謝、療效和毒性。隨著藥物研發人員將代謝體學整合到臨床前和臨床階段，以提高藥物的安全性和有效性，代謝體學試劑的需求也不斷成長。

質譜（MS）和核磁共振（NMR）是代謝體學中常用的主要分析技術。這些技術的進步，例如靈敏度和解析度的提高，推動了對高品質試劑的需求。隨著臨床檢查室和研究機構對這些平台的日益普及，試劑市場也從中受益。

代謝體學正與基因組學、蛋白質組學和轉錄組學相結合，以更全面地了解生物系統。這種多體學方法需要能夠跨平台應用並在不同研究中提供一致結果的試劑。

先進代謝體學平台（例如質譜（MS）和核磁共振（NMR））的購置和維修成本極為高昂。這些系統中使用的試劑也往往價格昂貴，尤其是在使用高純度、特殊試劑時。高成本限制了代謝體學工具的使用，使其僅限於資金雄厚的大型研究機構、製藥公司和臨床檢查室，限制了其在小規模實驗室和新興市場的應用潛力。

由於各實驗室之間缺乏標準化的通訊協定和試劑，不同研究的結果難以比較。試劑、儀器校準和實驗設計的差異會導致結果不一致，降低代謝體學資料的可信度。這種不一致阻礙了代謝體學作為臨床診斷和大規模研究可靠工具的推廣應用。

本報告目的是對全球代謝體學學試劑市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名，並依地區/國家、類型和應用對代謝體學試劑進行分析。

代謝體學試劑市場規模、估算和預測均以銷售收入為指標，以2024年為基準年，並包含2020年至2031年的歷史資料和預測資料。定量和定性分析將幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就代謝組學試劑做出明智的商業決策。

市場區隔

公司

  • Cambridge Isotope Laboratories
  • Biocrates
  • IROA Technologies
  • Fluidome
  • Metabolomix
  • Beijing BGI-GBI Biotech Co., Ltd.（GBI）
  • Metware Biotechnology
  • BIOTERE

依類型

  • 標靶代謝體學
  • 非標靶代謝體學

依應用

  • 生物相關企業
  • 研究機構
  • 教育機構

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Metabolomics Reagents was estimated to be worth US$ 29.4 million in 2024 and is forecast to a readjusted size of US$ 69.8 million by 2031 with a CAGR of 13.2% during the forecast period 2025-2031.

Metabolomics reagents are specialized chemicals, compounds, or materials used in metabolomics research to detect, quantify, and analyse metabolites (small molecules) within biological systems. Metabolomics refers to an array of techniques used to comprehensively detect and analyse various metabolites formed in vivo during biological activity. The qualitative and quantitative changes in metabolites reflect the ever-changing biological phenomena and are widely used for diagnosis, biomarker discovery, and drug discovery research. In recent years, metabolomics has been used in the food industry to improve taste and quality and to develop functional foods. It is also used in the biotechnology industry to improve fermentation and biofuel productivity.

Precision medicine aims to tailor treatments based on individual variability in genes, environment, and lifestyle. Metabolomics plays a critical role in identifying disease-specific biomarkers, leading to personalized treatment plans. This trend is accelerating the demand for reagents in clinical research and diagnostic applications.

Pharmaceutical companies are leveraging metabolomics to better understand drug metabolism, efficacy, and toxicity. The demand for metabolomics reagents is rising as drug developers integrate metabolomics into preclinical and clinical phases to improve drug safety and efficacy profiles.

MS and NMR are key analytical techniques used in metabolomics. Advancements in these technologies, such as increased sensitivity and higher resolution, are driving the need for high-quality reagents. The reagents market is benefitting from the growing adoption of these platforms in clinical labs and research institutions.

Metabolomics is increasingly being combined with genomics, proteomics, and transcriptomics to provide a more comprehensive understanding of biological systems. This multi-omics approach is creating a need for reagents that can function across different platforms and deliver consistent results across studies.

The cost of acquiring and maintaining advanced metabolomics platforms, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR), is very high. The reagents used in these systems are often expensive as well, especially when using high-purity, specialized reagents. This high cost limits the accessibility of metabolomics tools to large, well-funded research institutions, pharmaceutical companies, and clinical labs, reducing its potential in smaller labs and emerging markets.

There is a lack of standardized protocols and reagents across laboratories, which makes it difficult to compare results from different studies. Variability in reagents, instrument calibration, and experimental design can lead to inconsistent results, reducing confidence in metabolomics data. This inconsistency hampers efforts to establish metabolomics as a reliable tool in clinical diagnostics and large-scale studies.

This report aims to provide a comprehensive presentation of the global market for Metabolomics Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolomics Reagents by region & country, by Type, and by Application.

The Metabolomics Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Reagents.

Market Segmentation

By Company

  • Cambridge Isotope Laboratories
  • Biocrates
  • IROA Technologies
  • Fluidome
  • Metabolomix
  • Beijing BGI-GBI Biotech Co., Ltd. (GBI)
  • Metware Biotechnology
  • BIOTERE

Segment by Type

  • Targeted Metabolomics
  • Untargeted Metabolomics

Segment by Application

  • Biological Companies
  • Research Institutions
  • Educational Institutions

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Metabolomics Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Metabolomics Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Metabolomics Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Metabolomics Reagents Product Introduction
  • 1.2 Global Metabolomics Reagents Market Size Forecast (2020-2031)
  • 1.3 Metabolomics Reagents Market Trends & Drivers
    • 1.3.1 Metabolomics Reagents Industry Trends
    • 1.3.2 Metabolomics Reagents Market Drivers & Opportunity
    • 1.3.3 Metabolomics Reagents Market Challenges
    • 1.3.4 Metabolomics Reagents Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Metabolomics Reagents Players Revenue Ranking (2024)
  • 2.2 Global Metabolomics Reagents Revenue by Company (2020-2025)
  • 2.3 Key Companies Metabolomics Reagents Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Metabolomics Reagents Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Metabolomics Reagents
  • 2.6 Metabolomics Reagents Market Competitive Analysis
    • 2.6.1 Metabolomics Reagents Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Metabolomics Reagents Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Reagents as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Targeted Metabolomics
    • 3.1.2 Untargeted Metabolomics
  • 3.2 Global Metabolomics Reagents Sales Value by Type
    • 3.2.1 Global Metabolomics Reagents Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Metabolomics Reagents Sales Value, by Type (2020-2031)
    • 3.2.3 Global Metabolomics Reagents Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biological Companies
    • 4.1.2 Research Institutions
    • 4.1.3 Educational Institutions
  • 4.2 Global Metabolomics Reagents Sales Value by Application
    • 4.2.1 Global Metabolomics Reagents Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Metabolomics Reagents Sales Value, by Application (2020-2031)
    • 4.2.3 Global Metabolomics Reagents Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Metabolomics Reagents Sales Value by Region
    • 5.1.1 Global Metabolomics Reagents Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Metabolomics Reagents Sales Value by Region (2020-2025)
    • 5.1.3 Global Metabolomics Reagents Sales Value by Region (2026-2031)
    • 5.1.4 Global Metabolomics Reagents Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Metabolomics Reagents Sales Value, 2020-2031
    • 5.2.2 North America Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Metabolomics Reagents Sales Value, 2020-2031
    • 5.3.2 Europe Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Metabolomics Reagents Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Metabolomics Reagents Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Metabolomics Reagents Sales Value, 2020-2031
    • 5.5.2 South America Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Metabolomics Reagents Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Metabolomics Reagents Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Metabolomics Reagents Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Metabolomics Reagents Sales Value, 2020-2031
    • 6.3.2 United States Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Metabolomics Reagents Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Metabolomics Reagents Sales Value, 2020-2031
    • 6.4.2 Europe Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Metabolomics Reagents Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Metabolomics Reagents Sales Value, 2020-2031
    • 6.5.2 China Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Metabolomics Reagents Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Metabolomics Reagents Sales Value, 2020-2031
    • 6.6.2 Japan Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Metabolomics Reagents Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Metabolomics Reagents Sales Value, 2020-2031
    • 6.7.2 South Korea Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Metabolomics Reagents Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Metabolomics Reagents Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Metabolomics Reagents Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Metabolomics Reagents Sales Value, 2020-2031
    • 6.9.2 India Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Metabolomics Reagents Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Cambridge Isotope Laboratories
    • 7.1.1 Cambridge Isotope Laboratories Profile
    • 7.1.2 Cambridge Isotope Laboratories Main Business
    • 7.1.3 Cambridge Isotope Laboratories Metabolomics Reagents Products, Services and Solutions
    • 7.1.4 Cambridge Isotope Laboratories Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Cambridge Isotope Laboratories Recent Developments
  • 7.2 Biocrates
    • 7.2.1 Biocrates Profile
    • 7.2.2 Biocrates Main Business
    • 7.2.3 Biocrates Metabolomics Reagents Products, Services and Solutions
    • 7.2.4 Biocrates Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Biocrates Recent Developments
  • 7.3 IROA Technologies
    • 7.3.1 IROA Technologies Profile
    • 7.3.2 IROA Technologies Main Business
    • 7.3.3 IROA Technologies Metabolomics Reagents Products, Services and Solutions
    • 7.3.4 IROA Technologies Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IROA Technologies Recent Developments
  • 7.4 Fluidome
    • 7.4.1 Fluidome Profile
    • 7.4.2 Fluidome Main Business
    • 7.4.3 Fluidome Metabolomics Reagents Products, Services and Solutions
    • 7.4.4 Fluidome Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Fluidome Recent Developments
  • 7.5 Metabolomix
    • 7.5.1 Metabolomix Profile
    • 7.5.2 Metabolomix Main Business
    • 7.5.3 Metabolomix Metabolomics Reagents Products, Services and Solutions
    • 7.5.4 Metabolomix Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Metabolomix Recent Developments
  • 7.6 Beijing BGI-GBI Biotech Co., Ltd. (GBI)
    • 7.6.1 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Profile
    • 7.6.2 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Main Business
    • 7.6.3 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Products, Services and Solutions
    • 7.6.4 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Recent Developments
  • 7.7 Metware Biotechnology
    • 7.7.1 Metware Biotechnology Profile
    • 7.7.2 Metware Biotechnology Main Business
    • 7.7.3 Metware Biotechnology Metabolomics Reagents Products, Services and Solutions
    • 7.7.4 Metware Biotechnology Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Metware Biotechnology Recent Developments
  • 7.8 BIOTERE
    • 7.8.1 BIOTERE Profile
    • 7.8.2 BIOTERE Main Business
    • 7.8.3 BIOTERE Metabolomics Reagents Products, Services and Solutions
    • 7.8.4 BIOTERE Metabolomics Reagents Revenue (US$ Million) & (2020-2025)
    • 7.8.5 BIOTERE Recent Developments

8 Industry Chain Analysis

  • 8.1 Metabolomics Reagents Industrial Chain
  • 8.2 Metabolomics Reagents Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Metabolomics Reagents Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Metabolomics Reagents Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Metabolomics Reagents Market Trends
  • Table 2. Metabolomics Reagents Market Drivers & Opportunity
  • Table 3. Metabolomics Reagents Market Challenges
  • Table 4. Metabolomics Reagents Market Restraints
  • Table 5. Global Metabolomics Reagents Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Metabolomics Reagents Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Metabolomics Reagents Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Metabolomics Reagents Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Metabolomics Reagents
  • Table 10. Global Metabolomics Reagents Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Reagents as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Metabolomics Reagents Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Metabolomics Reagents Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Metabolomics Reagents Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Metabolomics Reagents Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Metabolomics Reagents Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Metabolomics Reagents Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Metabolomics Reagents Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Metabolomics Reagents Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Metabolomics Reagents Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Metabolomics Reagents Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Metabolomics Reagents Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Metabolomics Reagents Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Metabolomics Reagents Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Metabolomics Reagents Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Metabolomics Reagents Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Metabolomics Reagents Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Metabolomics Reagents Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Metabolomics Reagents Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Cambridge Isotope Laboratories Basic Information List
  • Table 32. Cambridge Isotope Laboratories Description and Business Overview
  • Table 33. Cambridge Isotope Laboratories Metabolomics Reagents Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Metabolomics Reagents Business of Cambridge Isotope Laboratories (2020-2025)
  • Table 35. Cambridge Isotope Laboratories Recent Developments
  • Table 36. Biocrates Basic Information List
  • Table 37. Biocrates Description and Business Overview
  • Table 38. Biocrates Metabolomics Reagents Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Metabolomics Reagents Business of Biocrates (2020-2025)
  • Table 40. Biocrates Recent Developments
  • Table 41. IROA Technologies Basic Information List
  • Table 42. IROA Technologies Description and Business Overview
  • Table 43. IROA Technologies Metabolomics Reagents Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Metabolomics Reagents Business of IROA Technologies (2020-2025)
  • Table 45. IROA Technologies Recent Developments
  • Table 46. Fluidome Basic Information List
  • Table 47. Fluidome Description and Business Overview
  • Table 48. Fluidome Metabolomics Reagents Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Metabolomics Reagents Business of Fluidome (2020-2025)
  • Table 50. Fluidome Recent Developments
  • Table 51. Metabolomix Basic Information List
  • Table 52. Metabolomix Description and Business Overview
  • Table 53. Metabolomix Metabolomics Reagents Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Metabolomics Reagents Business of Metabolomix (2020-2025)
  • Table 55. Metabolomix Recent Developments
  • Table 56. Beijing BGI-GBI Biotech Co., Ltd. (GBI) Basic Information List
  • Table 57. Beijing BGI-GBI Biotech Co., Ltd. (GBI) Description and Business Overview
  • Table 58. Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Metabolomics Reagents Business of Beijing BGI-GBI Biotech Co., Ltd. (GBI) (2020-2025)
  • Table 60. Beijing BGI-GBI Biotech Co., Ltd. (GBI) Recent Developments
  • Table 61. Metware Biotechnology Basic Information List
  • Table 62. Metware Biotechnology Description and Business Overview
  • Table 63. Metware Biotechnology Metabolomics Reagents Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Metabolomics Reagents Business of Metware Biotechnology (2020-2025)
  • Table 65. Metware Biotechnology Recent Developments
  • Table 66. BIOTERE Basic Information List
  • Table 67. BIOTERE Description and Business Overview
  • Table 68. BIOTERE Metabolomics Reagents Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Metabolomics Reagents Business of BIOTERE (2020-2025)
  • Table 70. BIOTERE Recent Developments
  • Table 71. Key Raw Materials Lists
  • Table 72. Raw Materials Key Suppliers Lists
  • Table 73. Metabolomics Reagents Downstream Customers
  • Table 74. Metabolomics Reagents Distributors List
  • Table 75. Research Programs/Design for This Report
  • Table 76. Key Data Information from Secondary Sources
  • Table 77. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Metabolomics Reagents Product Picture
  • Figure 2. Global Metabolomics Reagents Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Metabolomics Reagents Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Metabolomics Reagents Report Years Considered
  • Figure 5. Global Metabolomics Reagents Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Metabolomics Reagents Revenue in 2024
  • Figure 7. Metabolomics Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Targeted Metabolomics Picture
  • Figure 9. Untargeted Metabolomics Picture
  • Figure 10. Global Metabolomics Reagents Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Metabolomics Reagents Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Biological Companies
  • Figure 13. Product Picture of Research Institutions
  • Figure 14. Product Picture of Educational Institutions
  • Figure 15. Global Metabolomics Reagents Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Metabolomics Reagents Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Metabolomics Reagents Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Metabolomics Reagents Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Metabolomics Reagents Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Metabolomics Reagents Sales Value (%), (2020-2031)
  • Figure 28. United States Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Metabolomics Reagents Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Metabolomics Reagents Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Metabolomics Reagents Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Metabolomics Reagents Industrial Chain
  • Figure 50. Metabolomics Reagents Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed